Insider Transactions in Q1 2021 at Bio Techne Corp (TECH)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 16
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,428
-9.89%
|
$7,162,908
$411.0 P/Share
|
Feb 16
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.54%
|
$2,820,000
$94.35 P/Share
|
Feb 12
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
10,000
-38.29%
|
$3,980,000
$398.76 P/Share
|
Feb 12
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.28%
|
$1,060,000
$106.59 P/Share
|
Feb 12
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
10,000
-27.64%
|
$4,000,000
$400.92 P/Share
|
Feb 12
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.32%
|
$1,060,000
$106.59 P/Share
|
Feb 08
2021
|
Roeland Nusse Director |
SELL
Open market or private sale
|
Direct |
6,000
-47.0%
|
$2,310,000
$385.08 P/Share
|
Feb 08
2021
|
Roeland Nusse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+19.78%
|
$408,000
$68.63 P/Share
|
Feb 05
2021
|
Norman David Eansor President-Protein Sciences |
SELL
Open market or private sale
|
Direct |
32,933
-35.67%
|
$12,547,473
$381.75 P/Share
|
Feb 05
2021
|
Norman David Eansor President-Protein Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
32,933
+41.62%
|
$3,490,898
$106.59 P/Share
|
Feb 05
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
823
-49.34%
|
$319,324
$388.45 P/Share
|
Jan 15
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-12.03%
|
$6,880,000
$344.0 P/Share
|
Jan 11
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
10,000
-11.1%
|
$3,320,000
$332.19 P/Share
|
Jan 11
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.32%
|
$1,060,000
$106.59 P/Share
|